With post hoc analysis, BridgeBio touts case for acoramidis as FDA decision date draws near 0 27.09.2024 21:51 Fiercebiotech.com With post hoc analysis, BridgeBio touts case for acoramidis as FDA decision date draws near dincorvaia Fri, 09/27/2024 - 14:51
